Pediatric Home Healthcare Market Updates

Global Pediatric Home Healthcare Market size was valued at USD 37.2 billion in 2023 and is poised to grow from USD 40.14 billion in 2024 to USD 73.75 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032). 

In the home healthcare market, the pediatric care service is a booming segment that presents operators with tremendous opportunities to grow their businesses. The greatest income-generating specialty for BAYADA Home Health Care, one of the market's key participants, and the source of nearly one-third of its revenue is pediatric nursing services. 'AstraZeneca plc (United Kingdom) ', 'Pfizer Inc. (United States) ', 'Sanofi S.A. (France) ', 'Boehringer Ingelheim GmbH (Germany) ', 'Eisai Co., Ltd. (Japan) ', 'Gilead Sciences, Inc. (United States) ', 'GlaxoSmithKline plc (United Kingdom) ', 'Merck & Co., Inc. (United States) ', 'Novartis AG (Switzerland) ', 'Johnson & Johnson (United States) ', 'Eli Lilly and Company (United States) ', 'Bristol-Myers Squibb Company (United States) ', 'Amedisys Inc. (United States) ', 'Maxim Healthcare Services (United States) ', 'Cardinal Health, Inc. (United States) ', 'B. Braun Melsungen AG (Germany) ', 'Team Select Home Care (United States) ', 'Portea Medical (India)'

Pediatric home health care essentially consists of medical facilities that offer children medical services to enhance their health and support their entire development. For support, family members are also present in the medical facility.

Due to the ongoing COVID-19 pandemic, there will likely be an increase in the need for home care services in the near future. These services are both affordable and safe substitutes for healthcare services external alternatives, such as hospitals. The threat posed by informal care and other healthcare facilities is limited, mostly because to their high prices. Hence, the market's threat from replacement products throughout the forecast period, is anticipated to be moderate.

Due to rising awareness of pediatric home-based medical services, North America dominated the global pediatric home healthcare market and held the greatest revenue share of close to 35.0 %. Nearly 500,000 newborns and adolescents with exceptional medical requirements require various medical and therapeutic assistance in their homes, according to a report on children with complicated medical disorders in the U.S. Long-term hospital stays can considerably raise medical costs, whereas pediatric home-based therapies are more affordable and enhance patient care. As a result, a wide variety of suppliers in the U.S. are providing a range of services to satisfy this expanding need.